Hepatitis C Articles (HCV)
Back
 
We know DAAs work for PWID, now what? Simplifying HCV testing, linkage to care and treatment
Download the PDF here
 
Reported by Jules Levin
NATAP
www.natap.org
 
Associate Professor Jason Grebely
National Drug & Alcohol Research Centre, Sydney, Australia, 17th May 2018
Reported by Jules Levin
NATAP
www.natap.org
 
Associate Professor Jason Grebely
National Drug & Alcohol Research Centre, Sydney, Australia, 17th May 2018
EASL:
The PREVAIL Study: Intensive Models of HCV Care for People Who Inject Drugs
- (04/26/17)
 
EASL:
Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: The SIMPLIFY study
- (04/24/17)
 
C-EDGE CO-STAR: Interim Results From the 3-year Follow-up Trial on Risk Factors and Rate of Reinfection in Patients on Opiate Agonist Therapy Previously Treated With Elbasvir/Grazoprevir for 12 Weeks
View Older Articles
Back to Top
www.natap.org